IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Derma Silk is a Proprietary Company that generates the majority of its income from the Pharmaceutical Product Manufacturing industry. In 2023 the company generated total revenue of $74,587,000 including sales and other revenue. In 2023 Derma Silk had 53 employees including employees from all subsidiaries under the company's control. The Chief Executive Officer of Derma Silk is either not applicable or not available.The Chairman of Derma Silk is either not applicable or not available. Link offer the following products: Acetylcysteine Adrenaline-Link Allmercap Colistin Link Dapsone Erythromycin-Link Etopophos Foscavir Hydralazine Link Imukin Kamrab Mercaptopurine-Link Mysoline Natulan Pentothal Pitressin Qarziba Relistor Syvant Trexject VepesidLink offer the following services: Clinical trial supply Early Access Programs Unregistered supply Registered medicines Sourcing medicines for shortages
Answer any industry question in minutes with our entire database at your fingertips.
Feed trusted, human-driven industry intelligence straight into your platform.
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
IBISWorld's research coverage on the Link Healthcare Pty Limited includes market sizing, forecasting, data and analysis. The most recent publication will be as current as of March 2026.
Link Healthcare Pty Limited, trading as Derma Silk, operates under the ABN 13 117 371 632 and was incorporated on 30 November 2005. Link Healthcare Pty Limited primarily operates in the Pharmaceutical Product Manufacturing industry in Australia.
The Key Personnel chapter outlines the principal leadership positions within Link Healthcare Pty Limited, including the Chairman, Board members, Chief Executive Officer, and other key management personnel. It provides an overview of the company’s governance and executive structure, along with a breakdown of gender diversity across leadership roles, offering insight into the composition of the organisation’s senior team.
The Financials chapter presents Link Healthcare Pty Limited’s historical financial performance, including detailed profit and loss statements outlining sales revenue, cost of sales, and profitability. It also incorporates balance sheet data, providing a breakdown of assets and liabilities, as well as additional financial metrics such as the number of shares on issue. Together, these disclosures offer a comprehensive view of the company’s financial position and performance over time.
The Growth & Ratios chapter provides historical data on key financial performance indicators, enabling an assessment of the company’s operational efficiency, profitability, and financial structure over time. Metrics covered include return on equity, return on assets, profit margins, revenue per employee, as well as gearing and leverage ratios, offering a comprehensive view of performance trends and capital management.
The Operating Segments chapter provides an overview of the revenue composition and asset allocation across the various industries in which Link Healthcare Pty Limited operates. It offers insights into how the company’s financial performance is distributed among its core business segments, highlighting the relative contribution of each industry to total revenue.
The Competitor Benchmarking chapter includes a comparative assessment of Link Healthcare Pty Limited’s key financial, growth, and valuation ratios against industry averages to evaluate its competitive position. It analyses valuation metrics such as price-to-earnings, price-to-book, enterprise value to EBITDA, and enterprise value to sales, alongside core financial indicators including liquidity ratios and profitability measures.
The Shareholders chapter provides a breakdown of the ownership structure of Link Healthcare Pty Limited, identifying key shareholders and outlining their respective ownership interests. This section offers insight into the concentration of shareholdings, the presence of institutional or strategic investors, and the overall distribution of equity within the company.
The Subsidiaries chapter provides an overview of the companies and business entities that are wholly or partially owned by Link Healthcare Pty Limited. It outlines the ownership structure of each subsidiary, offering insight into the broader corporate group and how these entities contribute to the company’s overall activities and performance.
The History chapter presents a overview of Link Healthcare Pty Limited’s development, highlighting key milestones and significant corporate events since its incorporation. It includes the company’s incorporation date and outlines major strategic, operational, and structural developments, providing context for its evolution and current market position.
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
Link offer the following products: Acetylcysteine Adrenaline-Link Allmercap Colistin Link Dapsone Erythromycin-Link Etopophos Foscavir Hydralazine Link Imukin Kamrab Mercaptopurine-Link Mysoline Natulan Pentothal Pitressin Qarziba Relistor Syvant Trexject VepesidLink offer the following services: Clinical trial supply Early Access Programs Unregistered supply Registered medicines Sourcing medicines for shortages
Link Healthcare Pty Limited, trading as Derma Silk, is a Private Company that generates the majority of its income from the Pharmaceutical Product Manufacturing industry in Australia.
Murray Cod Australia Limited company is based at 5 Apollo Street, Warriewood, New South Wales, Australia.
The OPERATIONS DECISION MAKER of Link Healthcare Pty Limited is Jonathan Rossiter and the OPERATIONS DECISION MAKER is Julie Body.
In 2025, Link Healthcare Pty Limited generated total revenue of approximately $74.6 million.